Clinical Trials Directory

Trials / Completed

CompletedNCT04819646

Evaluate the Effects of a Marine Lipid Oil Concentrate Formulation on Inflammation/Discomfort

An Open-label, Single-arm Study to Evaluate the Effects of a Marine Lipid Oil Concentrate Formulation on Inflammation/Discomfort in Individuals Who Are Generally Healthy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
31 (actual)
Sponsor
Supplement Formulators, Inc. · Industry
Sex
All
Age
35 Years – 75 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to assess the efficacy and safety of a Marine Lipid Oil Concentrate formulation on inflammation/discomfort and overall well-being in male and female subjects who are generally healthy

Detailed description

This is an open-label, single-arm remote study to evaluate the effects of a Marine Lipid Oil Concentrate formulation on inflammation/discomfort and overall well-being in individuals who are generally healthy. Each subject will receive a specific dose of the study products to be taken once daily for a total of 60 days. Participants complete assessments and questionnaires. The primary objective is the evaluation of the change in the responses to the SF-36 (Short-Form-36) Health Survey, Medical Symptoms questionnaire, Pain questionnaire and responses on an assessment form relative to baseline. Safety and tolerability will be evaluated through receipt of documentation and responses from the telephone contacts/emails as per protocol.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMarine Lipid Oil Concentrate FormulationMarine Lipid Oil Concentrate softgels
DIETARY_SUPPLEMENTDietary SupplementDietary Supplement capsules

Timeline

Start date
2021-01-07
Primary completion
2021-09-03
Completion
2021-11-02
First posted
2021-03-29
Last updated
2023-01-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04819646. Inclusion in this directory is not an endorsement.